Rybelsus stands out as a game changer in the management of type 2 diabetes. This oral medication, the first of its kind in the GLP-1 receptor agonist category, offers a new option for patients seeking effective blood sugar control. Rybelsus operates by mimicking the action of incretin hormones, which the…